Beijing Lvzhu Biological Technology Co.
Latest round
- Series C
Last raised
- Jun 2022
Total raised
- $73M
Investors
- 11
About Beijing Lvzhu Biological Technology Co.
,Ltd. is a biological technology company that focuses on the development of human vaccines and therapeutic monoclonal antibodies. In 2002, the company launched a quantitative detection kit for meningococcal polysaccharide antibodies of groups A and C to the market. In 2010, the company started the research and development of antibody drugs. In 2018, the company established a subsidiary Lvzhu Biopharmaceutical in Zhuhai.79 million in an IPO and listed on the Hongkong stock exchange. The company engages in the development of human vaccines and therapeutic monoclonal antibodies. Its main products include recombinant vaccines, double antibody injections and enzyme-linked kits, etc. The products of the company include Group A Meningococcal Polysaccharide IgG Antibody Kit , Group C Meningococcal Polysaccharide IgG Antibody Kit , Group Y Meningococcal Polysaccharide IgG Antibody Kit, etc. K193 antibody injection is a bispecific antibody targeting human CD19 and CD3e, used to treat B-cell lymphoma and leukemia. The company will accelerate the clinical trial of the company's own innovative recombinant herpes zoster vaccine, LZ901, in China and the United States, and clinical phase I/II studies of a bifunctional antibody CD19-CD3 for the treatment of relapsed/refractory B-cell leukemia (ALL) and for the treatment of relapsed/refractory B-cell non-Hodgkin's lymphoma (NHL).
Who invested in Beijing Lvzhu Biological Technology Co.
11 investors across 4 rounds
See all investors in Beijing Lvzhu Biological Technology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Beijing Lvzhu Biological Technology Co.
Who invested in Beijing Lvzhu Biological Technology Co.?
Beijing Lvzhu Biological Technology Co. has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beijing Lvzhu Biological Technology Co. raised?
Beijing Lvzhu Biological Technology Co. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Beijing Lvzhu Biological Technology Co. last raise money?
Beijing Lvzhu Biological Technology Co.'s most recent round on record is a Series C, in Jun 2022.
What does Beijing Lvzhu Biological Technology Co. do?
Beijing Lvzhu Biological Technology Co. is a biotechnology company.
Where is Beijing Lvzhu Biological Technology Co. headquartered?
Beijing Lvzhu Biological Technology Co. is headquartered in Beijing, China.
Which VCs invest in companies like Beijing Lvzhu Biological Technology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Beijing Lvzhu Biological Technology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Beijing Lvzhu Biological Technology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.